版本:
中国

BRIEF-Immunocellular Therapeutics Q1 loss per share $1.64

May 15 Immunocellular Therapeutics Ltd:

* Immunocellular Therapeutics announces first quarter 2017 financial results

* Q1 loss per share $1.64

* Immunocellular Therapeutics Ltd - Company considering potential strategic alternatives for ICT-107

* Immunocellular Therapeutics Ltd - in light of uncertainties surrounding strategic pursuits, company is deferring a Business Update Conference Call

* Immunocellular Therapeutics - also intends to evaluate strategies to refocus and reallocate resources on stem-To-T-Cell Research Programs Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐